About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

NOG 重度免疫不全暨人源化小鼠研討會

 

在過去的幾十年裡,免疫缺陷小鼠已經成為了生物醫學研究領域的一項重要工具,其獨特的特性使其成為瘤生物學、免疫學、藥理學、生物製劑的安全性評估、活性篩選實驗,以及異體移植領域之理想模型。經濟生技醫藥產業發展推動小組、中華實驗動物學會與Central Institute for Experimental Medicine and Life Science誠摯地邀請您參加即將於4月17日舉辦的「NOG 重度免疫不全暨人源化小鼠研討會」,此場會議將邀請日本專家分享動物試驗領域之專業知識,會議將聚焦於重度免疫不全小鼠(NOG Mouse)在生物醫學領域中之應用,期待與您互相交流該領域最新研究成果與未來發展方向,並期望藉此建立未來雙邊合作之基礎。

 

日期:2024年4月17日 10:00-11:40

會議形式:線上會議

報名鏈結:點我報名

語言:英語

【主辦單位】中華實驗動物學會;經濟部生技醫藥產業發展推動小組;Central Institute for Experimental Medicine and Life Science.

【協辦單位】In-Vivo Science Inc.、麥德凱生科股份有限公司、太和儀器有限公司

【研討會議程】

時間

會議議程

09:30~10:00

報到

10:00~10:10

長官致詞

10:10~10:40

專題演講 一

題目:Microbiological monitoring and infectious disease of NOG mice

演講者:林元 展人Nobuhito Hayashimoto DVM, Ph.D., DJCLAM, MBA

現職:

  • Central Institute for Experimental Medicine and Life Science (CIEM)
  • Vice Chair, Basic Technology Division
  • Director, ICLAS Monitoring Center

主持人:方美佐 理事長

10:40~11:40

專題演講 二

題目:Latest information on humanized immunodeficient mice as a “cancer/immunology research tool”

演講者:山本 大地Taichi Yamamoto Ph.D.

現職:

  • Central Institute for Experimental Medicine and Life Science (CIEM)
  • Translational Research, Division Vice Chair
  • In-Vivo Science Inc., Board Member

主持人:方美佐 理事長

 

【注意事項】

此會議為線上會議,請預先上網至報名系統完成報名,主辦單位將於會議開始前2天寄送會議連結。

本研討會免費參加。

 

【聯繫方式】

如有任何問題,請隨時通過以下方式與我們聯繫。

經濟部生技醫藥產業發展推動小組

李經理

電話:02-2655-8133#113

電子郵件:pmli@biopharm.org.tw

 

【附件下載】